294 related articles for article (PubMed ID: 30225986)
1. Impaired histaminergic neurotransmission in children with narcolepsy type 1.
Franco P; Dauvilliers Y; Inocente CO; Guyon A; Villanueva C; Raverot V; Plancoulaine S; Lin JS
CNS Neurosci Ther; 2019 Mar; 25(3):386-395. PubMed ID: 30225986
[TBL] [Abstract][Full Text] [Related]
2. Normal cerebrospinal fluid histamine and tele-methylhistamine levels in hypersomnia conditions.
Dauvilliers Y; Delallée N; Jaussent I; Scholz S; Bayard S; Croyal M; Schwartz JC; Robert P
Sleep; 2012 Oct; 35(10):1359-66. PubMed ID: 23024434
[TBL] [Abstract][Full Text] [Related]
3. Temporal Changes in the Cerebrospinal Fluid Level of Hypocretin-1 and Histamine in Narcolepsy.
Lopez R; Barateau L; Evangelista E; Chenini S; Robert P; Jaussent I; Dauvilliers Y
Sleep; 2017 Jan; 40(1):. PubMed ID: 28364477
[TBL] [Abstract][Full Text] [Related]
4. Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls.
Nishino S; Sakurai E; Nevsimalova S; Yoshida Y; Watanabe T; Yanai K; Mignot E
Sleep; 2009 Feb; 32(2):175-80. PubMed ID: 19238804
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal Fluid Histamine Levels in Healthy Children and Potential Implication for SIDS: Observational Study in a French Tertiary Care Hospital.
Plancoulaine S; Guyon A; Inocente CO; Germe P; Zhang M; Robert P; Lin JS; Franco P
Front Pediatr; 2022; 10():819496. PubMed ID: 35450108
[TBL] [Abstract][Full Text] [Related]
6. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.
Mignot E; Lammers GJ; Ripley B; Okun M; Nevsimalova S; Overeem S; Vankova J; Black J; Harsh J; Bassetti C; Schrader H; Nishino S
Arch Neurol; 2002 Oct; 59(10):1553-62. PubMed ID: 12374492
[TBL] [Abstract][Full Text] [Related]
7. Hypocretin (orexin) levels in cerebrospinal fluid of patients with narcolepsy: relationship to cataplexy and HLA DQB1*0602 status.
Krahn LE; Pankratz VS; Oliver L; Boeve BF; Silber MH
Sleep; 2002 Nov; 25(7):733-6. PubMed ID: 12405608
[TBL] [Abstract][Full Text] [Related]
8. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
Nishino S; Kanbayashi T
Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
[TBL] [Abstract][Full Text] [Related]
9. CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome.
Kanbayashi T; Kodama T; Kondo H; Satoh S; Inoue Y; Chiba S; Shimizu T; Nishino S
Sleep; 2009 Feb; 32(2):181-7. PubMed ID: 19238805
[TBL] [Abstract][Full Text] [Related]
10. Narcolepsy without cataplexy: 2 subtypes based on CSF hypocretin-1/orexin-A findings.
Oka Y; Inoue Y; Kanbayashi T; Kuroda K; Miyamoto M; Miyamoto T; Ikeda A; Shimizu T; Hishikawa Y; Shibasaki H
Sleep; 2006 Nov; 29(11):1439-43. PubMed ID: 17162990
[TBL] [Abstract][Full Text] [Related]
11. The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A).
Bassetti C; Gugger M; Bischof M; Mathis J; Sturzenegger C; Werth E; Radanov B; Ripley B; Nishino S; Mignot E
Sleep Med; 2003 Jan; 4(1):7-12. PubMed ID: 14592354
[TBL] [Abstract][Full Text] [Related]
12. Hypocretin (orexin) deficiency predicts severe objective excessive daytime sleepiness in narcolepsy with cataplexy.
Baumann CR; Khatami R; Werth E; Bassetti CL
J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):402-4. PubMed ID: 16484654
[TBL] [Abstract][Full Text] [Related]
13. Undetectable levels of CSF hypocretin-1 (orexin-A) in two prepubertal boys with narcolepsy.
Tsukamoto H; Ishikawa T; Fujii Y; Fukumizu M; Sugai K; Kanbayashi T
Neuropediatrics; 2002 Feb; 33(1):51-2. PubMed ID: 11930279
[TBL] [Abstract][Full Text] [Related]
14. CSF levels of the histamine metabolite tele-methylhistamine are only slightly decreased in Alzheimer's disease.
Motawaj M; Peoc'h K; Callebert J; Arrang JM
J Alzheimers Dis; 2010; 22(3):861-71. PubMed ID: 20858978
[TBL] [Abstract][Full Text] [Related]
15. Relationship between clinical characteristics of narcolepsy and CSF orexin-A levels.
Nakamura M; Kanbayashi T; Sugiura T; Inoue Y
J Sleep Res; 2011 Mar; 20(1 Pt 1):45-9. PubMed ID: 20642748
[TBL] [Abstract][Full Text] [Related]
16. A preliminary study investigating the clinical potential of measuring cerebrospinal-fluid lactate levels in patients with narcolepsy type 1 and 2.
Fernandes M; Spanetta M; Placidi F; Izzi F; Negri F; Nuccetelli M; Bernardini S; Mercuri NB; Liguori C
Physiol Behav; 2023 Dec; 272():114371. PubMed ID: 37802459
[TBL] [Abstract][Full Text] [Related]
17. Narcolepsies, update in 2023.
Barateau L; Pizza F; Chenini S; Peter-Derex L; Dauvilliers Y
Rev Neurol (Paris); 2023 Oct; 179(7):727-740. PubMed ID: 37634997
[TBL] [Abstract][Full Text] [Related]
18. Cataplexy with Normal Sleep Studies and Normal CSF Hypocretin: An Explanation?
Drakatos P; Leschziner G
J Clin Sleep Med; 2016 Mar; 12(3):449-50. PubMed ID: 26564387
[TBL] [Abstract][Full Text] [Related]
19. Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy.
Nishino S; Ripley B; Overeem S; Nevsimalova S; Lammers GJ; Vankova J; Okun M; Rogers W; Brooks S; Mignot E
Ann Neurol; 2001 Sep; 50(3):381-8. PubMed ID: 11558795
[TBL] [Abstract][Full Text] [Related]
20. Intermediate hypocretin-1 cerebrospinal fluid levels and typical cataplexy: their significance in the diagnosis of narcolepsy type 1.
van der Hoeven AE; Fronczek R; Schinkelshoek MS; Roelandse FWC; Bakker JA; Overeem S; Bijlenga D; Lammers GJ
Sleep; 2022 May; 45(5):. PubMed ID: 35554594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
